Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Ivan Bascon, Molecular Bioscience and Biotechnology, B.S., Paul J Christos, Dr.P.H., M.S., Maria Teresa De Sancho, MD MSc

Blood (2019) 134 (Supplement_1): 3657.

https://doi.org/10.1182/blood-2019-132248

Published: 2019

Journal Articles

Recurrent Thrombosis in Patients with Antiphospholipid Antibodies and Arterial Thrombosis Treated with Antiplatelets and/or Anticoagulant Therapy

William G Jackson, MDcal Student, Clara Oromendia, MS, Ozan Unlu, MD, Doruk Erkan, MD MPH, Maria Teresa De Sancho, MD MSc

Blood (2016) 128 (22): 86.

https://doi.org/10.1182/blood.V128.22.86.86

Published: 2016

Journal Articles

Efficiency of Diagnosing HIT at a Large Academic Medical Center

Marcia N Paddock, MD PhD, Bryce Clark, Maria Teresa De Sancho, MD MSc

Blood (2015) 126 (23): 2059.

https://doi.org/10.1182/blood.V126.23.2059.2059

Published: 2015

Journal Articles

Cyclophosphamide Efficacy and Toxicities in the First Line Treatment of Acquired Hemophilia

John C. Chapin, MD, Maria Teresa De Sancho, MD MSc, Sarah C. Rutherford, MD

Blood (2014) 124 (21): 5055.

https://doi.org/10.1182/blood.V124.21.5055.5055

Published: 2014

Journal Articles

Evaluating Adherence To Clinical Guidelines For Thrombophilia Screening

Amy Kwon, Mikhail Roshal, MD, PhD, Maria Teresa De Sancho, MD, MSc

Blood (2013) 122 (21): 1692.

https://doi.org/10.1182/blood.V122.21.1692.1692

Published: 2013

Journal Articles

Recombinant Interferon Alpha (rIFN) May Retard Progression Of Early Myelofibrosis By Reducing Splenomegaly and By Decreasing Marrow Fibrosis

Richard T. Silver, Elena Lascu, Eric J. Feldman, MD, Ellen Ritchie, MD, Gail J. Roboz, MD, Maria Teresa De Sancho, MD, MSc, Ruth Bauman, Attilio Orazi, MD

Blood (2013) 122 (21): 4053.

https://doi.org/10.1182/blood.V122.21.4053.4053

Published: 2013

Journal Articles

Outcomes In Adult Hemophilia and Von Willebrand Disease Patients Undergoing Surgical and Invasive Procedures

John C. Chapin, MD, Jacqueline Bamme, MD, Fraustina Hsu, Paul Christos, Maria Teresa De Sancho, MD, MSc

Blood (2013) 122 (21): 1120.

https://doi.org/10.1182/blood.V122.21.1120.1120

Published: 2013

NARROW

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Recurrent Thrombosis in Patients with Antiphospholipid Antibodies and Arterial Thrombosis Treated with Antiplatelets and/or Anticoagulant Therapy

Efficiency of Diagnosing HIT at a Large Academic Medical Center

Cyclophosphamide Efficacy and Toxicities in the First Line Treatment of Acquired Hemophilia

Evaluating Adherence To Clinical Guidelines For Thrombophilia Screening

Recombinant Interferon Alpha (rIFN) May Retard Progression Of Early Myelofibrosis By Reducing Splenomegaly and By Decreasing Marrow Fibrosis

Outcomes In Adult Hemophilia and Von Willebrand Disease Patients Undergoing Surgical and Invasive Procedures

Email alerts

ASH Publications

American Society of Hematology

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Recurrent Thrombosis in Patients with Antiphospholipid Antibodies and Arterial Thrombosis Treated with Antiplatelets and/or Anticoagulant Therapy

Efficiency of Diagnosing HIT at a Large Academic Medical Center

Cyclophosphamide Efficacy and Toxicities in the First Line Treatment of Acquired Hemophilia

Evaluating Adherence To Clinical Guidelines For Thrombophilia Screening

Recombinant Interferon Alpha (rIFN) May Retard Progression Of Early Myelofibrosis By Reducing Splenomegaly and By Decreasing Marrow Fibrosis

Outcomes In Adult Hemophilia and Von Willebrand Disease Patients Undergoing Surgical and Invasive Procedures

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only